Addex Therapeutics Ltd
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. Show More...
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.06 CHF
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CHF -5.69 -4.19 -3.36 -1.6 -0.18 -0.39 -0.28 -0.25 -0.07 -0.56 -0.6 Dividends CHF Payout Ratio % * Shares Mil 6.0 7.0 8.0 9.0 10.0 11.0 11.0 13.0 23.0 26.0 26.0 Book Value Per Share * CHF 9.54 6.47 2.26 0.29 0.21 0.25 0.1 0.18 1.6 1.21 0.82 Free Cash Flow Per Share * CHF -7.03 -3.84 -3.81 -2.94 -0.66 -0.19 -0.22 -0.19 0.14 -0.24 Return on Assets % -41.32 -52.83 -82.69 -104.74 -35.93 -122.06 -137.75 -138.24 -7.27 -39.29 -55.57 Financial Leverage (Average) 1.15 1.28 1.33 1.94 1.7 1.74 7.7 2.28 1.08 1.29 1.33 Return on Equity % -47.39 -63.39 -107.8 -149.73 -66.08 -209.69 -334.54 -420.26 -8.11 -45.64 -73.67 Return on Invested Capital % -47.32 -63.05 -107.89 -149.78 -66.14 -202.1 -333.81 -414.45 -7.02 -44.6 -71.89 Interest Coverage -231.34 -129.1 -26.62 -453.85 -71.34 -6.47 -114.0 -136.84 Current Ratio 7.17 4.36 3.66 1.65 1.42 2.7 1.33 2.07 18.06 5.7 5.0 Quick Ratio 6.88 4.13 3.7 1.92 1.43 2.69 1.31 2.17 18.09 5.57 4.81 Debt/Equity 0.010